Search

Charanjit Aulakh

Examiner (ID: 2304, Phone: (571)272-0678 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1612, 1625, 1203, 1621
Total Applications
3771
Issued Applications
2863
Pending Applications
382
Abandoned Applications
583

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17815386 [patent_doc_number] => 11420984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Arginase inhibitors and methods of use thereof [patent_app_type] => utility [patent_app_number] => 16/969739 [patent_app_country] => US [patent_app_date] => 2019-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29788 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16969739 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/969739
Arginase inhibitors and methods of use thereof Feb 14, 2019 Issued
Array ( [id] => 15227383 [patent_doc_number] => 10501401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-10 [patent_title] => Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 16/275165 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43857 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275165 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/275165
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof Feb 12, 2019 Issued
Array ( [id] => 14963017 [patent_doc_number] => 20190308986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => PROCESS FOR IMPROVED OPIOID SYNTHESIS [patent_app_type] => utility [patent_app_number] => 16/270969 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44624 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16270969 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/270969
PROCESS FOR IMPROVED OPIOID SYNTHESIS Feb 7, 2019 Abandoned
Array ( [id] => 14375157 [patent_doc_number] => 20190161491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 16/265286 [patent_app_country] => US [patent_app_date] => 2019-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7402 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265286 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/265286
Methods for the chemical synthesis of pyrrole-linked bivalent compounds, and compositions thereof Jan 31, 2019 Issued
Array ( [id] => 16628671 [patent_doc_number] => 20210047324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/966176 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966176 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/966176
SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF Jan 30, 2019 Abandoned
Array ( [id] => 15396043 [patent_doc_number] => 10538666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Compound, polymer, film, and optical device [patent_app_type] => utility [patent_app_number] => 16/263355 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 15031 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 326 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263355 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/263355
Compound, polymer, film, and optical device Jan 30, 2019 Issued
Array ( [id] => 16621442 [patent_doc_number] => 20210040095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/966170 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12334 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966170 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/966170
Spiro-lactam NMDA receptor modulators and uses thereof Jan 30, 2019 Issued
Array ( [id] => 14375159 [patent_doc_number] => 20190161492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-30 [patent_title] => PROCESS FOR PREPARING OXYCODONE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/262683 [patent_app_country] => US [patent_app_date] => 2019-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16262683 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/262683
Process for preparing oxycodone compositions Jan 29, 2019 Issued
Array ( [id] => 17022283 [patent_doc_number] => 20210246154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => RUTHENIUM COMPLEX CONTAINING ALKYNYL GROUP, METHOD OF SYNTHESIZING THE SAME AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/050458 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050458 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/050458
Ruthenium complex containing alkynyl group, method of synthesizing the same and use thereof Jan 24, 2019 Issued
Array ( [id] => 14581207 [patent_doc_number] => 20190218212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => HETEROARYL COMPOUNDS FOR KINASE INHIBITION [patent_app_type] => utility [patent_app_number] => 16/257577 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67931 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16257577 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/257577
HETEROARYL COMPOUNDS FOR KINASE INHIBITION Jan 24, 2019 Abandoned
Array ( [id] => 16444843 [patent_doc_number] => 10836755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Cardiac sarcomere inhibitors [patent_app_type] => utility [patent_app_number] => 16/252483 [patent_app_country] => US [patent_app_date] => 2019-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61209 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/252483
Cardiac sarcomere inhibitors Jan 17, 2019 Issued
Array ( [id] => 18085487 [patent_doc_number] => 11535604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => Fasoracetam crystalline forms [patent_app_type] => utility [patent_app_number] => 16/963494 [patent_app_country] => US [patent_app_date] => 2019-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 7005 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963494 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/963494
Fasoracetam crystalline forms Jan 16, 2019 Issued
Array ( [id] => 14531513 [patent_doc_number] => 20190201377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS [patent_app_type] => utility [patent_app_number] => 16/247880 [patent_app_country] => US [patent_app_date] => 2019-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9602 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247880 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/247880
METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS Jan 14, 2019 Abandoned
16/317627 INHIBITORS OF CYCLIN DEPENDENT KINASE 7 (CDK7) Jan 13, 2019 Abandoned
Array ( [id] => 16711802 [patent_doc_number] => 20210078949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => METHODS FOR PREPARATION OF JASMONATE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/960089 [patent_app_country] => US [patent_app_date] => 2019-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5516 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960089 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/960089
Methods for preparation of jasmonate compounds Jan 5, 2019 Issued
Array ( [id] => 14566733 [patent_doc_number] => 20190210973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => COMPOUNDS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/240679 [patent_app_country] => US [patent_app_date] => 2019-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44632 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 335 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240679 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/240679
COMPOUNDS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS Jan 3, 2019 Abandoned
Array ( [id] => 16657342 [patent_doc_number] => 20210053978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/955975 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -55 [patent_words_short_claim] => 291 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955975 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955975
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof Dec 20, 2018 Issued
Array ( [id] => 19012987 [patent_doc_number] => 11919902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-05 [patent_title] => Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors [patent_app_type] => utility [patent_app_number] => 16/956953 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84938 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 634 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956953 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/956953
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors Dec 20, 2018 Issued
Array ( [id] => 18443819 [patent_doc_number] => 11679372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-20 [patent_title] => Multivariate metal-organic frameworks for fine-tuning light emission [patent_app_type] => utility [patent_app_number] => 16/956781 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 16190 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956781 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/956781
Multivariate metal-organic frameworks for fine-tuning light emission Dec 20, 2018 Issued
Array ( [id] => 18013257 [patent_doc_number] => 11505539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders [patent_app_type] => utility [patent_app_number] => 16/955998 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15509 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955998 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955998
Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders Dec 20, 2018 Issued
Menu